Stay updated with breaking news from West Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
VANCOUVER, BC / ACCESSWIRE / October 27, 2022 / EastWest Bioscience Inc. (the "Company" or "EastWest") (TSXV:EAST) announces the proposed issuance of 1,436,020 common shares at a price of CDN $0.05 per
PENTICTON, BC / ACCESSWIRE / April 6, 2022 / EastWest Bioscience Inc. ("EastWest" or "Company") (TSXV:EAST), announced that it has filed its Quarterly Financials and MD&A under its profile on SEDAR with
Press release content from Accesswire. The AP news staff was not involved in its creation.
PENTICTON, BC / ACCESSWIRE / March 23, 2022 / EastWest Bioscience Inc. ("EastWest" or "Company") (TSXV:EAST), reports that, pursuant to the Board of Directors Ancillary Compensation Agreement (the "Compensation
VANCOUVER, BC / ACCESSWIRE / November 24, 2021 / EastWest Bioscience Inc. (the "Company" or "EastWest") (TSXV:EAST) announces the issuance of 3,095,044 common shares at a price of CDN $0.05 per common